Clinical Trials
All Clinical Trials - Page 16 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06439277Phase 3Recruiting
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Tirzepatide
- NCT06426446N/AUnknown
Monitoring Patients With Severe Obesity Treated With Wegovy® Using Connected Device: Real-world Data
Semaglutide
- NCT06451120Phase 2Active Not Recruiting
Platelet Rich Plasma Injections In Young And Old Human Subjects
Ghrp-6
- NCT02586831Phase 1/Phase 2Withdrawn
Diabetes Islet Preservation Immune Treatment
Exenatide
- NCT04626141Phase 4Withdrawn
Supracondylar Distal Femur Fractures and Abaloparatide
Abaloparatide
- NCT06263595N/ACompleted
Semaglutide and Preoperative Residual Gastric Volumes
Semaglutide
- NCT05796388N/ARecruiting
A Study of Virtual Reality and Linaclotide for IBS-C
Linaclotide
- NCT06373731Phase 3Active Not Recruiting
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)
Elamipretide
- NCT06500130N/ACompleted
Effects of Liraglutide on Body Surface Gastric Mapping
Liraglutide
- NCT06195709Phase 3Recruiting
ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients
Gonadorelin
- NCT06439056Phase 1Completed
Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D
Liraglutide
- NCT06445075Phase 2Completed
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Tirzepatide
- NCT06400615Phase 2Completed
Study That Tests AD109 in Patients Taking GLP-1 Drugs
Tirzepatide
- NCT06409130Phase 2Completed
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
Semaglutide
- NCT06925334Phase 4Enrolling By Invitation
A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus
Liraglutide
- NCT06318442N/ARecruiting
The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
Semaglutide
- NCT06352411Phase 1Completed
A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems
Survodutide
- NCT06821919N/ARecruiting
Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
Semaglutide
- NCT06403761Phase 1Completed
Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
Semaglutide
- NCT06449703Phase 1Unknown
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects
Liraglutide
- NCT06370728Phase 1Completed
A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants
Orforglipron
- NCT06438146Phase 4Unknown
LIROH - Liraglutide for Obesity in HIV
Liraglutide
- NCT06361823Phase 3Unknown
Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
Semaglutide
- NCT06401746N/ACompleted
Body Surface Gastric Mapping in Patients on Semaglutide
Semaglutide
- NCT06287307Phase 4Unknown
Semaglutide 2.4mg for Low Responders After Bariatric Surgery
Semaglutide
- NCT06383390Phase 3Active Not Recruiting
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Retatrutide
- NCT06423599Phase 2/Phase 3Recruiting
Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
Semaglutide
- NCT06408532Phase 4Unknown
The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
Liraglutide
- NCT06352424Phase 1Completed
A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity
Survodutide
- NCT06282458Phase 2Completed
Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
Semaglutide
- NCT06352892Phase 1Completed
A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight
Maridebart-Cafraglutide
- NCT06373146Phase 2Completed
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Tirzepatide
- NCT06173778Phase 2Recruiting
Semaglutide for Post-Smoking Cessation Weight Management
Semaglutide
- NCT07836140Phase 2Completed
A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.
Semaglutide
- NCT06292065N/ACompleted
Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy
Semaglutide
- NCT07814651Phase 2Completed
A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With Acromegaly
Octreotide
- NCT06297616Phase 1Completed
A Study of LY3841136 in Japanese Participants With Obesity or Overweight
Tirzepatide
- NCT06354660Phase 3Completed
Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
Retatrutide
- NCT06283641N/ACompleted
Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.
Liraglutide
- NCT06235086Phase 3Completed
A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
Dulaglutide
- NCT05822609Phase 2Recruiting
Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Semaglutide
- NCT06345066Phase 1Completed
A Study of LY3841136 in Overweight and Obese Participants
Tirzepatide
- NCT06309992Phase 3Completed
A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)
Survodutide
- NCT06131372Phase 2Completed
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
Semaglutide
- NCT06390501N/ACompleted
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
Semaglutide
- NCT06552598Phase 1Recruiting
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Thymosin-Alpha-1
- NCT06339086Phase 3Unknown
Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
Semaglutide
- NCT07590219Phase 4Active Not Recruiting
Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity
Liraglutide
- NCT06255366Phase 4Unknown
Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion
Desmopressin
- NCT06323161Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin
Semaglutide